Cargando…
Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114954/ https://www.ncbi.nlm.nih.gov/pubmed/30181818 http://dx.doi.org/10.18632/oncotarget.26009 |
| _version_ | 1783351293616586752 |
|---|---|
| author | Cao, Ling Yang, Yong-Jing Diao, Jian-Dong Zhang, Xu-He Liu, Yan-Ling Wang, Bo-Yu Li, Zhi-Wen Liu, Shi-Xin |
| author_facet | Cao, Ling Yang, Yong-Jing Diao, Jian-Dong Zhang, Xu-He Liu, Yan-Ling Wang, Bo-Yu Li, Zhi-Wen Liu, Shi-Xin |
| author_sort | Cao, Ling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6114954 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61149542018-09-04 Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis Cao, Ling Yang, Yong-Jing Diao, Jian-Dong Zhang, Xu-He Liu, Yan-Ling Wang, Bo-Yu Li, Zhi-Wen Liu, Shi-Xin Oncotarget Correction Impact Journals LLC 2018-08-14 /pmc/articles/PMC6114954/ /pubmed/30181818 http://dx.doi.org/10.18632/oncotarget.26009 Text en Copyright: © 2018 Cao et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Cao, Ling Yang, Yong-Jing Diao, Jian-Dong Zhang, Xu-He Liu, Yan-Ling Wang, Bo-Yu Li, Zhi-Wen Liu, Shi-Xin Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| title | Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| title_full | Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| title_fullStr | Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| title_full_unstemmed | Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| title_short | Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| title_sort | correction: systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114954/ https://www.ncbi.nlm.nih.gov/pubmed/30181818 http://dx.doi.org/10.18632/oncotarget.26009 |
| work_keys_str_mv | AT caoling correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT yangyongjing correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT diaojiandong correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT zhangxuhe correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT liuyanling correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT wangboyu correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT lizhiwen correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis AT liushixin correctionsystematicreviewandmetaanalysiscomparingzoledronicacidadministeredat12weekand4weekintervalsinpatientswithbonemetastasis |